Global Oncology Biomarker Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 317300
  • calendar_today Published On: Jul, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Oncology Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Oncology Biomarker market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Diagnostics accounting for % of the Oncology Biomarker global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Lung Cancer segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Oncology Biomarker include Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, F.Hoffmann-La Roche Ltd., and Genomic Health, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Oncology Biomarker market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Lung Cancer

Breast Cancer

Colorectal Cancer

Prostate Cancer

Stomach Cancer

Others

Market segment by Application, can be divided into

Diagnostics

Drug Discovery And Development

Prognostics

Risk Assessment

Others

Market segment by players, this report covers

Abbott Laboratories

Bristol-Myers Squibb

Eli Lilly and Company

F.Hoffmann-La Roche Ltd.

Genomic Health

GlaxoSmithKline plc

Novartis AG

Merck & Co.

Pfizer

Qiagen N.V.

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Oncology Biomarker product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Oncology Biomarker, with revenue, gross margin and global market share of Oncology Biomarker from 2019 to 2022.

Chapter 3, the Oncology Biomarker competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Oncology Biomarker market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Oncology Biomarker research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Oncology Biomarker

1.2 Classification of Oncology Biomarker by Type

1.2.1 Overview: Global Oncology Biomarker Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Oncology Biomarker Revenue Market Share by Type in 2021

1.2.3 Lung Cancer

1.2.4 Breast Cancer

1.2.5 Colorectal Cancer

1.2.6 Prostate Cancer

1.2.7 Stomach Cancer

1.2.8 Others

1.3 Global Oncology Biomarker Market by Application

1.3.1 Overview: Global Oncology Biomarker Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Diagnostics

1.3.3 Drug Discovery And Development

1.3.4 Prognostics

1.3.5 Risk Assessment

1.3.6 Others

1.4 Global Oncology Biomarker Market Size & Forecast

1.5 Global Oncology Biomarker Market Size and Forecast by Region

1.5.1 Global Oncology Biomarker Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Oncology Biomarker Market Size by Region, (2017-2022)

1.5.3 North America Oncology Biomarker Market Size and Prospect (2017-2028)

1.5.4 Europe Oncology Biomarker Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Oncology Biomarker Market Size and Prospect (2017-2028)

1.5.6 South America Oncology Biomarker Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Oncology Biomarker Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Oncology Biomarker Market Drivers

1.6.2 Oncology Biomarker Market Restraints

1.6.3 Oncology Biomarker Trends Analysis

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Oncology Biomarker Product and Solutions

2.1.4 Abbott Laboratories Oncology Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Abbott Laboratories Recent Developments and Future Plans

2.2 Bristol-Myers Squibb

2.2.1 Bristol-Myers Squibb Details

2.2.2 Bristol-Myers Squibb Major Business

2.2.3 Bristol-Myers Squibb Oncology Biomarker Product and Solutions

2.2.4 Bristol-Myers Squibb Oncology Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.3 Eli Lilly and Company

2.3.1 Eli Lilly and Company Details

2.3.2 Eli Lilly and Company Major Business

2.3.3 Eli Lilly and Company Oncology Biomarker Product and Solutions

2.3.4 Eli Lilly and Company Oncology Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Eli Lilly and Company Recent Developments and Future Plans

2.4 F.Hoffmann-La Roche Ltd.

2.4.1 F.Hoffmann-La Roche Ltd. Details

2.4.2 F.Hoffmann-La Roche Ltd. Major Business

2.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Product and Solutions

2.4.4 F.Hoffmann-La Roche Ltd. Oncology Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 F.Hoffmann-La Roche Ltd. Recent Developments and Future Plans

2.5 Genomic Health

2.5.1 Genomic Health Details

2.5.2 Genomic Health Major Business

2.5.3 Genomic Health Oncology Biomarker Product and Solutions

2.5.4 Genomic Health Oncology Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Genomic Health Recent Developments and Future Plans

2.6 GlaxoSmithKline plc

2.6.1 GlaxoSmithKline plc Details

2.6.2 GlaxoSmithKline plc Major Business

2.6.3 GlaxoSmithKline plc Oncology Biomarker Product and Solutions

2.6.4 GlaxoSmithKline plc Oncology Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 GlaxoSmithKline plc Recent Developments and Future Plans

2.7 Novartis AG

2.7.1 Novartis AG Details

2.7.2 Novartis AG Major Business

2.7.3 Novartis AG Oncology Biomarker Product and Solutions

2.7.4 Novartis AG Oncology Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Novartis AG Recent Developments and Future Plans

2.8 Merck & Co.

2.8.1 Merck & Co. Details

2.8.2 Merck & Co. Major Business

2.8.3 Merck & Co. Oncology Biomarker Product and Solutions

2.8.4 Merck & Co. Oncology Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Merck & Co. Recent Developments and Future Plans

2.9 Pfizer

2.9.1 Pfizer Details

2.9.2 Pfizer Major Business

2.9.3 Pfizer Oncology Biomarker Product and Solutions

2.9.4 Pfizer Oncology Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Pfizer Recent Developments and Future Plans

2.10 Qiagen N.V.

2.10.1 Qiagen N.V. Details

2.10.2 Qiagen N.V. Major Business

2.10.3 Qiagen N.V. Oncology Biomarker Product and Solutions

2.10.4 Qiagen N.V. Oncology Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Qiagen N.V. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Oncology Biomarker Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Oncology Biomarker Players Market Share in 2021

3.2.2 Top 10 Oncology Biomarker Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Oncology Biomarker Players Head Office, Products and Services Provided

3.4 Oncology Biomarker Mergers & Acquisitions

3.5 Oncology Biomarker New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Oncology Biomarker Revenue and Market Share by Type (2017-2022)

4.2 Global Oncology Biomarker Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Oncology Biomarker Revenue Market Share by Application (2017-2022)

5.2 Global Oncology Biomarker Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Oncology Biomarker Revenue by Type (2017-2028)

6.2 North America Oncology Biomarker Revenue by Application (2017-2028)

6.3 North America Oncology Biomarker Market Size by Country

6.3.1 North America Oncology Biomarker Revenue by Country (2017-2028)

6.3.2 United States Oncology Biomarker Market Size and Forecast (2017-2028)

6.3.3 Canada Oncology Biomarker Market Size and Forecast (2017-2028)

6.3.4 Mexico Oncology Biomarker Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Oncology Biomarker Revenue by Type (2017-2028)

7.2 Europe Oncology Biomarker Revenue by Application (2017-2028)

7.3 Europe Oncology Biomarker Market Size by Country

7.3.1 Europe Oncology Biomarker Revenue by Country (2017-2028)

7.3.2 Germany Oncology Biomarker Market Size and Forecast (2017-2028)

7.3.3 France Oncology Biomarker Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Oncology Biomarker Market Size and Forecast (2017-2028)

7.3.5 Russia Oncology Biomarker Market Size and Forecast (2017-2028)

7.3.6 Italy Oncology Biomarker Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Oncology Biomarker Revenue by Type (2017-2028)

8.2 Asia-Pacific Oncology Biomarker Revenue by Application (2017-2028)

8.3 Asia-Pacific Oncology Biomarker Market Size by Region

8.3.1 Asia-Pacific Oncology Biomarker Revenue by Region (2017-2028)

8.3.2 China Oncology Biomarker Market Size and Forecast (2017-2028)

8.3.3 Japan Oncology Biomarker Market Size and Forecast (2017-2028)

8.3.4 South Korea Oncology Biomarker Market Size and Forecast (2017-2028)

8.3.5 India Oncology Biomarker Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Oncology Biomarker Market Size and Forecast (2017-2028)

8.3.7 Australia Oncology Biomarker Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Oncology Biomarker Revenue by Type (2017-2028)

9.2 South America Oncology Biomarker Revenue by Application (2017-2028)

9.3 South America Oncology Biomarker Market Size by Country

9.3.1 South America Oncology Biomarker Revenue by Country (2017-2028)

9.3.2 Brazil Oncology Biomarker Market Size and Forecast (2017-2028)

9.3.3 Argentina Oncology Biomarker Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Oncology Biomarker Revenue by Type (2017-2028)

10.2 Middle East & Africa Oncology Biomarker Revenue by Application (2017-2028)

10.3 Middle East & Africa Oncology Biomarker Market Size by Country

10.3.1 Middle East & Africa Oncology Biomarker Revenue by Country (2017-2028)

10.3.2 Turkey Oncology Biomarker Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Oncology Biomarker Market Size and Forecast (2017-2028)

10.3.4 UAE Oncology Biomarker Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Oncology Biomarker Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Oncology Biomarker Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Oncology Biomarker Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Oncology Biomarker Revenue (USD Million) by Region (2017-2022)

Table 5. Global Oncology Biomarker Revenue Market Share by Region (2023-2028)

Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Laboratories Major Business

Table 8. Abbott Laboratories Oncology Biomarker Product and Solutions

Table 9. Abbott Laboratories Oncology Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 11. Bristol-Myers Squibb Major Business

Table 12. Bristol-Myers Squibb Oncology Biomarker Product and Solutions

Table 13. Bristol-Myers Squibb Oncology Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors

Table 15. Eli Lilly and Company Major Business

Table 16. Eli Lilly and Company Oncology Biomarker Product and Solutions

Table 17. Eli Lilly and Company Oncology Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. F.Hoffmann-La Roche Ltd. Corporate Information, Head Office, and Major Competitors

Table 19. F.Hoffmann-La Roche Ltd. Major Business

Table 20. F.Hoffmann-La Roche Ltd. Oncology Biomarker Product and Solutions

Table 21. F.Hoffmann-La Roche Ltd. Oncology Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Genomic Health Corporate Information, Head Office, and Major Competitors

Table 23. Genomic Health Major Business

Table 24. Genomic Health Oncology Biomarker Product and Solutions

Table 25. Genomic Health Oncology Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. GlaxoSmithKline plc Corporate Information, Head Office, and Major Competitors

Table 27. GlaxoSmithKline plc Major Business

Table 28. GlaxoSmithKline plc Oncology Biomarker Product and Solutions

Table 29. GlaxoSmithKline plc Oncology Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Novartis AG Corporate Information, Head Office, and Major Competitors

Table 31. Novartis AG Major Business

Table 32. Novartis AG Oncology Biomarker Product and Solutions

Table 33. Novartis AG Oncology Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Merck & Co. Corporate Information, Head Office, and Major Competitors

Table 35. Merck & Co. Major Business

Table 36. Merck & Co. Oncology Biomarker Product and Solutions

Table 37. Merck & Co. Oncology Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Pfizer Corporate Information, Head Office, and Major Competitors

Table 39. Pfizer Major Business

Table 40. Pfizer Oncology Biomarker Product and Solutions

Table 41. Pfizer Oncology Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Qiagen N.V. Corporate Information, Head Office, and Major Competitors

Table 43. Qiagen N.V. Major Business

Table 44. Qiagen N.V. Oncology Biomarker Product and Solutions

Table 45. Qiagen N.V. Oncology Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Oncology Biomarker Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Oncology Biomarker Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Oncology Biomarker by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Oncology Biomarker Players Head Office, Products and Services Provided

Table 50. Oncology Biomarker Mergers & Acquisitions in the Past Five Years

Table 51. Oncology Biomarker New Entrants and Expansion Plans

Table 52. Global Oncology Biomarker Revenue (USD Million) by Type (2017-2022)

Table 53. Global Oncology Biomarker Revenue Share by Type (2017-2022)

Table 54. Global Oncology Biomarker Revenue Forecast by Type (2023-2028)

Table 55. Global Oncology Biomarker Revenue by Application (2017-2022)

Table 56. Global Oncology Biomarker Revenue Forecast by Application (2023-2028)

Table 57. North America Oncology Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Oncology Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Oncology Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Oncology Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Oncology Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Oncology Biomarker Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Oncology Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Oncology Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Oncology Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Oncology Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Oncology Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Oncology Biomarker Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Oncology Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Oncology Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Oncology Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Oncology Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Oncology Biomarker Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Oncology Biomarker Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Oncology Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Oncology Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Oncology Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Oncology Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Oncology Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Oncology Biomarker Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Oncology Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Oncology Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Oncology Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Oncology Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Oncology Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Oncology Biomarker Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Oncology Biomarker Picture

Figure 2. Global Oncology Biomarker Revenue Market Share by Type in 2021

Figure 3. Lung Cancer

Figure 4. Breast Cancer

Figure 5. Colorectal Cancer

Figure 6. Prostate Cancer

Figure 7. Stomach Cancer

Figure 8. Others

Figure 9. Oncology Biomarker Revenue Market Share by Application in 2021

Figure 10. Diagnostics Picture

Figure 11. Drug Discovery And Development Picture

Figure 12. Prognostics Picture

Figure 13. Risk Assessment Picture

Figure 14. Others Picture

Figure 15. Global Oncology Biomarker Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 16. Global Oncology Biomarker Revenue and Forecast (2017-2028) & (USD Million)

Figure 17. Global Oncology Biomarker Revenue Market Share by Region (2017-2028)

Figure 18. Global Oncology Biomarker Revenue Market Share by Region in 2021

Figure 19. North America Oncology Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Europe Oncology Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Asia-Pacific Oncology Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. South America Oncology Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Middle East and Africa Oncology Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. Oncology Biomarker Market Drivers

Figure 25. Oncology Biomarker Market Restraints

Figure 26. Oncology Biomarker Market Trends

Figure 27. Abbott Laboratories Recent Developments and Future Plans

Figure 28. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 29. Eli Lilly and Company Recent Developments and Future Plans

Figure 30. F.Hoffmann-La Roche Ltd. Recent Developments and Future Plans

Figure 31. Genomic Health Recent Developments and Future Plans

Figure 32. GlaxoSmithKline plc Recent Developments and Future Plans

Figure 33. Novartis AG Recent Developments and Future Plans

Figure 34. Merck & Co. Recent Developments and Future Plans

Figure 35. Pfizer Recent Developments and Future Plans

Figure 36. Qiagen N.V. Recent Developments and Future Plans

Figure 37. Global Oncology Biomarker Revenue Share by Players in 2021

Figure 38. Oncology Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 39. Global Top 3 Players Oncology Biomarker Revenue Market Share in 2021

Figure 40. Global Top 10 Players Oncology Biomarker Revenue Market Share in 2021

Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 42. Global Oncology Biomarker Revenue Share by Type in 2021

Figure 43. Global Oncology Biomarker Market Share Forecast by Type (2023-2028)

Figure 44. Global Oncology Biomarker Revenue Share by Application in 2021

Figure 45. Global Oncology Biomarker Market Share Forecast by Application (2023-2028)

Figure 46. North America Oncology Biomarker Sales Market Share by Type (2017-2028)

Figure 47. North America Oncology Biomarker Sales Market Share by Application (2017-2028)

Figure 48. North America Oncology Biomarker Revenue Market Share by Country (2017-2028)

Figure 49. United States Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Canada Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Mexico Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Europe Oncology Biomarker Sales Market Share by Type (2017-2028)

Figure 53. Europe Oncology Biomarker Sales Market Share by Application (2017-2028)

Figure 54. Europe Oncology Biomarker Revenue Market Share by Country (2017-2028)

Figure 55. Germany Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. France Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. United Kingdom Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Russia Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Italy Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Asia-Pacific Oncology Biomarker Sales Market Share by Type (2017-2028)

Figure 61. Asia-Pacific Oncology Biomarker Sales Market Share by Application (2017-2028)

Figure 62. Asia-Pacific Oncology Biomarker Revenue Market Share by Region (2017-2028)

Figure 63. China Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Japan Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South Korea Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. India Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Southeast Asia Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Australia Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. South America Oncology Biomarker Sales Market Share by Type (2017-2028)

Figure 70. South America Oncology Biomarker Sales Market Share by Application (2017-2028)

Figure 71. South America Oncology Biomarker Revenue Market Share by Country (2017-2028)

Figure 72. Brazil Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Argentina Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Middle East and Africa Oncology Biomarker Sales Market Share by Type (2017-2028)

Figure 75. Middle East and Africa Oncology Biomarker Sales Market Share by Application (2017-2028)

Figure 76. Middle East and Africa Oncology Biomarker Revenue Market Share by Country (2017-2028)

Figure 77. Turkey Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Saudi Arabia Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. UAE Oncology Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Methodology

Figure 81. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz